Epsilon M&A Deal Report - Unda
Transaction Multiples for the Valuation of Private Companies
Laboratoires Boiron / Unda
No EMAT :
17256
Announced Date :
27/05/2005
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Laboratoires Boiron
Target :
Unda
Country :
Belgium
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Manufactures homeopathic medicines > The sites of Brussels (Evere) and Aywaille (Harze) ensure the production and distribution of homeopathic medicines. > UNDA employs 166 people. > The UNDA...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
||
| Current |
|
|
|
|
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
| Date | Acquirer | Target | Country | Multiples | See details |
| 21/11/2006 | Crucell | SBL Vaccin | Sweden | ** | 17255 |
| 01/11/2006 | Allergan | Groupe Corneal Laboratoires | France | *** | 17254 |
Source: Epsilon Research / EMAT
